Phase II Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID-19
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to COVID-19
Related studies linked through entity extraction aliases.
Phase 2b/3 Trial of VSV-ΔG SARS-CoV-2 Vaccine (BRILIFE) Against Approved Comparator Vaccine.
- Status
- WITHDRAWN
- Phase
- PHASE2/PHASE3
Assessment of Diurnal Salivary Cortisol Production in COVID-19
- Status
- COMPLETED
- Phase
- N/A
ACTIV-5 / Big Effect Trial (BET-C) for the Treatment of COVID-19
- Status
- COMPLETED
- Phase
- PHASE2
Phase I Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID-19
- Status
- UNKNOWN
- Phase
- PHASE1
Chronic Multimorbidity Patterns in Relation to COVID-19 Severe Infection
- Status
- COMPLETED
- Phase
- N/A
Booster Vaccination Against COVID-19
- Status
- COMPLETED
- Phase
- PHASE2
Percutaneous Electrical Nerve Field Stimulation (PENFS) in Patients With Post Concussion Syndrome (PCS)
- Status
- RECRUITING
- Phase
- NA
The Opal - COVID-19 Study
- Status
- COMPLETED
- Phase
- N/A
Effectiveness of COVID-19 Vaccine for Prevention of COVID-19 in the Dominican Republic
- Status
- COMPLETED
- Phase
- N/A
Phase II/III Study of AZD2816, for the Prevention of COVID-19 in Adults
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
A Extension Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-612 COVID-19 Vaccine
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trial of Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Healthy Adults
- Status
- UNKNOWN
- Phase
- PHASE4
EPIC-HR: Study of Oral PF-07321332/Ritonavir Compared With Placebo in Nonhospitalized High Risk Adults With COVID-19
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
To Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of BNT162b2 Boosting Strategies Against COVID-19 in Participants ≥12 Years of Age.
- Status
- COMPLETED
- Phase
- PHASE3
Immunogenicity and Safety Study of Adjuvanted SARS-CoV-2 (SCB-2019) Vaccine in Adultsin China
- Status
- UNKNOWN
- Phase
- PHASE2
Immunogenicity and Safety of an Inactivated COVID-19 Vaccine
- Status
- COMPLETED
- Phase
- PHASE4
Effect of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Best Standard of Care for the Treatment of Hospitalized COVID-19 Patients and Continued Treatment Following Discharge
- Status
- COMPLETED
- Phase
- NA
Study on Sequential Immunization of Inactivated COVID-19 Vaccine and Recombinant COVID-19 Vaccine (Ad5 Vector) in Elderly Adults
- Status
- COMPLETED
- Phase
- PHASE4
Acupuncture Therapy for COVID-Related Olfactory Loss
- Status
- COMPLETED
- Phase
- NA